People get personal

Getting on and staying on insulin can be daunting. There’s a lot to learn and more to manage. But you’re not alone. Listen to the people who’ve come before you and have figured out ways to manage their diabetes and live full and productive lives. Here are their inspiring stories.

Frequently asked questions by people with diabetes like you

Need to know more about insulin? Here are some common questions that you may want to discuss further with your doctor when asking about Toujeo and Toujeo Max.

    Longer-acting insulin is designed to work like your body’s natural insulin production between meals and overnight to help control blood sugar.

    New to insulin    

    Toujeo may be an important step toward blood sugar control. Its release is slow and continuous with no peaks or wear-offs between doses. Toujeo can help blood sugar levels stay within the American Diabetes Association (ADA) target zone (80-130 mg/dL) around the clock. Toujeo should be taken once daily at the same time each day.

    Yes, but your doctor will determine which medications are right for you. Talk with your doctor about the medications and supplements you take, especially those called thiazolidinediones or TZDs because they can change how insulin works.

    Ask your doctor about any adjustments that need to be made to any other medications you might be taking while taking once-daily Toujeo.

    For all insulins, including Toujeo, the most common side effect is low blood sugar levels, called hypoglycemia. Ask your doctor about the signs and symptoms of hypoglycemia, how to monitor your blood sugar, and what to do if you have a hypoglycemic event.

    Find out more about side effects

    Yes, insulin glargine U-300 is an unbranded biologic for Toujeo, ensuring you have the same product experience as Toujeo. Learn more here.

From the makers of Toujeo

Insulin Glargine U-300 SoloStar® injection (insulin glargine injection) 300 units/mL logo
Insulin Glargine U-300 Max SoloStar® injection (insulin glargine injection) 300 units/mL logo
Winthrop, a Sanofi Company logo

Insulin glargine U-300—the unbranded biologic that is identical to Toujeo

Winthrop US is a Sanofi company dedicated to delivering unbranded versions of Sanofi products, including this unbranded biologic for Toujeo.

Insulin glargine U-300 is an unbranded biologic for Toujeo, ensuring you have the same product experience as Toujeo.

  • Insulin glargine U-300 uses the same manufacturing process as Toujeo
  • It is identical to Toujeo in molecular weight distribution, quality control parameters, and inactive ingredients
Comparison table of Toujeo® SoloStar® with Toujeo® Max SoloStar® and Insulin Glargine U-300 SoloStar with Insulin Glargine U-300 Max SoloStar®
Winthrop, a Sanofi Company logo

Learn more about WINTHROP

Winthrop, a Sanofi Company, is dedicated to ensuring patients get the same quality product they would from Sanofi’s brand name products. Winthrop products are identical to Sanofi products in molecular weight distribution, quality control parameters, inactive ingredients, and other key factors. Quality, affordability, and service are the foundation of our relationship with patients and those that serve them.

To find out more, please contact WinthropUS@sanofi.com.

Insulin glargine U-300 SoloStar injection and Insulin glargine U-300 Max SoloStar injection launched into the market on January 1, 2024. The availability in local markets will be dependent on payer coverage, pharmacy purchasing patterns, and wholesaler stocking decisions. This will take time and we do not expect broad coverage at launch. All major national and regional wholesalers have agreed to stock this new option.

TeamingUp For Diabetes logo

Join TeamingUp to get the support you need.

There’s a lot to think about when you live with diabetes. What you eat, how you exercise, and creating a routine are all essential to managing your diabetes well.

To do that you need a plan and you need support.

At TeamingUp, you’ll find tools, videos, and tips to get you and keep you on track. Learn how to plan and cook delicious meals, create exercise routines, and more. Hear from peers about how they’re living full lives with diabetes.

Chatbox icon

You’ve seen others’ stories. Now get help starting the conversation about Toujeo.

Whether you’re new to insulin or switching from another pen, you’ve got a guide to help you talk to your doctor about Toujeo. Download the guide most appropriate for you and don’t be afraid to speak up!

I'm new to insulin    

I'm considering switching insulin pens    

Piggybank icon

Pay no more than $35* per month for Toujeo Max

Use the Insurance Lookup tool to see if you’re covered.

Downward arrow on A1C bubble indicating reduction

Proven A1C reduction

Toujeo Max could help you control your A1C.

What are Toujeo and Insulin Glargine U-300 injection?

Prescription Toujeo and Insulin Glargine U-300 are long-acting man-made insulins used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus.

  • Toujeo and Insulin Glargine U-300 are not for the treatment of diabetic ketoacidosis
  • It is not known if Toujeo and Insulin Glargine U-300 are safe and effective in children under 6 years of age

What is Toujeo U-300 (insulin glargine) injection 300 Units/mL?

Prescription Toujeo is a long-acting man-made insulin used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus.

  • Toujeo is not for the treatment of diabetic ketoacidosis
  • It is not known if Toujeo is safe and effective in children under 6 years of age

Important Safety Information

Important Safety Information for Toujeo and Insulin Glargine U-300

Important Safety Information

The Important Safety Information for Insulin Glargine U-300 is the same as for Toujeo.

Do not use Toujeo if you have low blood sugar or if you are allergic to insulin or any of the ingredients in Toujeo.

Do not share your pen(s) with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

Before starting Toujeo, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant, or if you are breastfeeding or planning to breastfeed.

Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting pitted or thickened skin (lipodystrophy) and skin with lumps (localized cutaneous amyloidosis) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred, or damaged.

Heart failure can occur if you are taking insulin together with pills called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Toujeo. Your treatment with TZDs and Toujeo may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms including:

  • Shortness of breath
  • Sudden weight gain
  • Swelling of your ankles or feet

Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, and herbal supplements.

Toujeo should be taken at the same time once a day. Test your blood sugar levels daily while using any insulin. Do not change your dose or type of insulin without talking to your doctor. Verify you have the correct insulin before each injection. Do NOT use a syringe to remove Toujeo from your pen. Your dose for Toujeo may be different from other insulins you have taken. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Toujeo with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Use Toujeo only if the solution is clear and colorless with no particles visible.

While using Toujeo, do not drive or operate heavy machinery until you know how Toujeo affects you. Don’t drink alcohol or use other medicines that contain alcohol.

The most common side effect of Toujeo is low blood sugar (hypoglycemia), which may be serious and life-threatening. Severe hypoglycemia may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision. The long-acting effect of Toujeo may delay recovery from low blood sugar compared to shorter-acting insulins.

Toujeo may cause severe allergic reactions that can lead to death. Get medical help right away if you have:

  • A rash over your whole body
  • Shortness of breath
  • Swelling of your face, tongue, or throat
  • Extreme drowsiness, dizziness, or confusion
  • Trouble breathing
  • Fast heartbeat
  • Sweating

Toujeo may have additional side effects including swelling, weight gain, low potassium, and injection site reactions which may include change in fat tissue, skin thickening, redness, swelling, and itching.

Toujeo and Insulin Glargine U-300 SoloStar and Toujeo and Insulin Glargine U-300 Max SoloStar are single-patient-use prefilled insulin pens. It is important to perform a safety test when using a new pen for the first time. Talk to your doctor about proper injection technique and follow instructions in the Instruction Leaflet that comes with your Toujeo SoloStar or Toujeo Max SoloStar pen.

If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-1610.

The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.

*Eligibility Restrictions & Offer Terms:

Insulins Valyou Savings Program: This savings program is not insurance. For a complete list of participating brands, products, and National Drug Codes (NDCs) Click Here. This offer is not valid for prescriptions covered by or submitted for reimbursement, in whole or in part, under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial/private insurance. Only patients without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible cash paying patients will pay $35 per 30 Day Supply. To pay $35 per 30 Day Supply, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. Sanofi reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Upon registration, patients will receive all program details. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Insulins Valyou Savings Program at (833) 813-0190 (8:00 am-8:00 pm EST, Monday-Friday).

Sanofi Insulins Co-pay Savings Program: This savings program is not insurance. For a complete list of participating brands, products, and National Drug Codes (NDCs) Click Here. This offer is not valid for prescriptions covered by or submitted for reimbursement, in whole or in part, under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs. If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card. Please note: the Federal Employees Health Benefits (FEHB) Program is not a federal or state government health care program for purposes of the savings program. Void where prohibited by law. For the duration of the program, eligible commercially insured patients pay no more than $35 per 30-day supply, up to 10 packs per fill; Offer valid for one fill every 30 days. Savings may vary depending on patients’ out-of-pocket costs. The Sanofi Insulins Co-pay Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. Sanofi reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Upon registration, patients will receive all program details. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Sanofi Insulins Co-pay Savings Program at (866) 255-8661 (8:00 am-8:00 pm EST, Monday-Friday).

Important Safety Information

Important Safety Information for Toujeo and Insulin Glargine U-300

Important Safety Information

The Important Safety Information for Insulin Glargine U-300 is the same as for Toujeo.

Do not use Toujeo if you have low blood sugar or if you are allergic to insulin or any of the ingredients in Toujeo.

Do not share your pen(s) with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

Before starting Toujeo, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant, or if you are breastfeeding or planning to breastfeed.

Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting pitted or thickened skin (lipodystrophy) and skin with lumps (localized cutaneous amyloidosis) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred, or damaged.

Heart failure can occur if you are taking insulin together with pills called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Toujeo. Your treatment with TZDs and Toujeo may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms including:

  • Shortness of breath
  • Sudden weight gain
  • Swelling of your ankles or feet

Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, and herbal supplements.

Toujeo should be taken at the same time once a day. Test your blood sugar levels daily while using any insulin. Do not change your dose or type of insulin without talking to your doctor. Verify you have the correct insulin before each injection. Do NOT use a syringe to remove Toujeo from your pen. Your dose for Toujeo may be different from other insulins you have taken. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Toujeo with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Use Toujeo only if the solution is clear and colorless with no particles visible.

While using Toujeo, do not drive or operate heavy machinery until you know how Toujeo affects you. Don’t drink alcohol or use other medicines that contain alcohol.

The most common side effect of Toujeo is low blood sugar (hypoglycemia), which may be serious and life-threatening. Severe hypoglycemia may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision. The long-acting effect of Toujeo may delay recovery from low blood sugar compared to shorter-acting insulins.

Toujeo may cause severe allergic reactions that can lead to death. Get medical help right away if you have:

  • A rash over your whole body
  • Shortness of breath
  • Swelling of your face, tongue, or throat
  • Extreme drowsiness, dizziness, or confusion
  • Trouble breathing
  • Fast heartbeat
  • Sweating

Toujeo may have additional side effects including swelling, weight gain, low potassium, and injection site reactions which may include change in fat tissue, skin thickening, redness, swelling, and itching.

Toujeo and Insulin Glargine U-300 SoloStar and Toujeo and Insulin Glargine U-300 Max SoloStar are single-patient-use prefilled insulin pens. It is important to perform a safety test when using a new pen for the first time. Talk to your doctor about proper injection technique and follow instructions in the Instruction Leaflet that comes with your Toujeo SoloStar or Toujeo Max SoloStar pen.

If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-1610.

The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.

*Eligibility Restrictions & Offer Terms:

Insulins Valyou Savings Program: This savings program is not insurance. For a complete list of participating brands, products, and National Drug Codes (NDCs) Click Here. This offer is not valid for prescriptions covered by or submitted for reimbursement, in whole or in part, under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial/private insurance. Only patients without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible cash paying patients will pay $35 per 30 Day Supply. To pay $35 per 30 Day Supply, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. Sanofi reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Upon registration, patients will receive all program details. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Insulins Valyou Savings Program at (833) 813-0190 (8:00 am-8:00 pm EST, Monday-Friday).

Sanofi Insulins Co-pay Savings Program: This savings program is not insurance. For a complete list of participating brands, products, and National Drug Codes (NDCs) Click Here. This offer is not valid for prescriptions covered by or submitted for reimbursement, in whole or in part, under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs. If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card. Please note: the Federal Employees Health Benefits (FEHB) Program is not a federal or state government health care program for purposes of the savings program. Void where prohibited by law. For the duration of the program, eligible commercially insured patients pay no more than $35 per 30-day supply, up to 10 packs per fill; Offer valid for one fill every 30 days. Savings may vary depending on patients’ out-of-pocket costs. The Sanofi Insulins Co-pay Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. Sanofi reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Upon registration, patients will receive all program details. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Sanofi Insulins Co-pay Savings Program at (866) 255-8661 (8:00 am-8:00 pm EST, Monday-Friday).